Literature DB >> 8982149

Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes.

R Chatila1, A B West.   

Abstract

In adults with diabetes mellitus, hepatomegaly and abnormalities of liver enzymes occur as a consequence of hepatocellular glycogen accumulation, as has been well described in children. During periods of hyperglycemia glucose freely enters the hepatocytes driving glycogen synthesis, which is augmented further by administration of insulin to supraphysiologic levels. The accumulation of excessive amounts of glycogen in the hepatocytes is a function of intermittent episodes of hyperglycemia and hypoglycemia and the use of excessive insulin. Hepatic glycogenosis occurs in patients with poorly controlled insulin-dependent type I or type II diabetes. The clinical manifestations of this phenomenon may include abdominal pain and obstructive symptoms such as early satiety, nausea, and vomiting. Ascites has rarely been reported. The typical biochemical findings are mildly to moderately elevated aminotransferases, with or without mild elevations of alkaline phosphatase. Liver synthetic function is usually normal. All these abnormalities, including the hepatomegaly, are readily reversible with sustained euglycemic control. The other major cause of hepatomegaly in patients with diabetes is steatosis. This is a function of the body habitus and state of insulin resistance rather than glycemic control. However, the distinction between steatosis and glycogenosis is important: whereas steatosis may progress to fibrosis and cirrhosis, glycogenosis does not, but reflects the need for better diabetic control. Glycogenosis and steatosis cannot be distinguished reliably on ultrasound examination. The histology, however, is definitive. In glycogenosis, as in primary glycogen storage diseases, there is excess glycogen in the cytoplasm, and often also in the nucleus, of hepatocytes. The hepatocytes throughout the lobule appear pale and swollen with clearly defined cell boundaries. Ultrastructural examination reveals cytoplasmic glycogen in clumps displacing organelles to the periphery of the cell, and there is little if any steatosis. We have shown that hepatomegaly due to glycogenosis in adults with diabetes is similar in all respects to the condition seen in children. As in children, liver enzyme abnormalities are unreliable in predicting the presence or the extent of glycogenosis. Hepatic glycogenosis can occur at any age, and therefore should be included in the differential diagnosis of hepatomegaly in all insulin-requiring diabetics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982149     DOI: 10.1097/00005792-199611000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  41 in total

1.  Use of unripe plantain (Musa paradisiaca) in the management of diabetes and hepatic dysfunction in streptozotocin induced diabetes in rats.

Authors:  Chinedum O Eleazu; Polycarp Okafor
Journal:  Interv Med Appl Sci       Date:  2015-03-20

2.  Hepatic glycogenosis: an underrecognized source of abnormal liver function tests?

Authors:  Gregory S Sayuk; Jill E Elwing; Mauricio Lisker-Melman
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

3.  Association of diffuse liver glycogenosis and mild focal macrovesicular steatosis in a patient with poorly controlled type 1 diabetes.

Authors:  A Martocchia; M G Risicato; C Mattioli; M Antonelli; L Ruco; P Falaschi
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

4.  Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.

Authors:  D Nehrbass; F Klimek; P Bannasch
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Associated liver enzymes with hyperlipidemic profile in type 2 diabetes patients.

Authors:  Noura Al-Jameil; Farah A Khan; Sadia Arjumand; Mohammad F Khan; Hajera Tabassum
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Glycogenic hepatopathy in a Korean girl with poorly controlled type 1 diabetes mellitus.

Authors:  Hwal Rim Jeong; Young Seok Shim; Young Bae Kim; Hae Sang Lee; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-03-31

Review 7.  Hepatic glycogenosis: An underdiagnosed complication of diabetes mellitus?

Authors:  María Teresa Julián; Núria Alonso; Isabel Ojanguren; Eduarda Pizarro; Enric Ballestar; Manel Puig-Domingo
Journal:  World J Diabetes       Date:  2015-03-15

8.  Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats.

Authors:  Ilijana Grigorov; Desanka Bogojević; Sofija Jovanović; Anja Petrović; Svetlana Ivanović-Matić; Lidija Zolotarevski; Goran Poznanović; Vesna Martinović
Journal:  J Physiol Biochem       Date:  2014-03-07       Impact factor: 4.158

9.  Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver.

Authors:  Anja Petrović; Desanka Bogojević; Aleksandra Korać; Igor Golić; Sofija Jovanović-Stojanov; Vesna Martinović; Svetlana Ivanović-Matić; Jelena Stevanović; Goran Poznanović; Ilijana Grigorov
Journal:  J Physiol Biochem       Date:  2017-07-10       Impact factor: 4.158

10.  GLYCOGENIC HEPATOPATHY: A COMPLICATION OF UNCONTROLLED DIABETES.

Authors:  Medha Satyarengga; Yelena Zubatov; Sylvaine Frances; Gopal Narayanswami; Rodolfo J Galindo
Journal:  AACE Clin Case Rep       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.